Literature DB >> 22346318

Newer oral atypical antipsychotic agents: a review.

Jonathan R Scarff, David A Casey.   

Abstract

Year:  2011        PMID： 22346318      PMCID： PMC3278183     

Source DB:  PubMed          Journal:  P T        ISSN： 1052-1372


× No keyword cloud information.
  23 in total

1.  An update of fast-off dopamine D2 atypical antipsychotics.

Authors:  Philip Seeman
Journal:  Am J Psychiatry       Date:  2005-10       Impact factor: 18.112

2.  Paliperidone extended-release tablets for prevention of symptom recurrence in patients with schizophrenia: a randomized, double-blind, placebo-controlled study.

Authors:  Michelle Kramer; George Simpson; Valentinas Maciulis; Stuart Kushner; Ujjwala Vijapurkar; Pilar Lim; Mariëlle Eerdekens
Journal:  J Clin Psychopharmacol       Date:  2007-02       Impact factor: 3.153

3.  Medication satisfaction in schizophrenia: a blinded-initiation study of paliperidone extended release in patients suboptimally responsive to risperidone.

Authors:  Carla M Canuso; Augusto Grinspan; Amir Kalali; Chandrasekharrao Venkata Damaraju; Ursula Merriman; Larry Alphs; Awad George Awad
Journal:  Int Clin Psychopharmacol       Date:  2010-05       Impact factor: 1.659

4.  A randomized, placebo- and active-controlled study of paliperidone extended release for the treatment of acute manic and mixed episodes of bipolar I disorder.

Authors:  Eduard Vieta; Isaac F Nuamah; Pilar Lim; Eric C Yuen; Joseph M Palumbo; David W Hough; Joris Berwaerts
Journal:  Bipolar Disord       Date:  2010-05       Impact factor: 6.744

5.  Treatment of schizophrenia with paliperidone extended-release tablets: a 6-week placebo-controlled trial.

Authors:  J Kane; F Canas; M Kramer; L Ford; C Gassmann-Mayer; P Lim; M Eerdekens
Journal:  Schizophr Res       Date:  2006-11-07       Impact factor: 4.939

6.  Efficacy and safety of oral paliperidone extended-release tablets in the treatment of acute schizophrenia: pooled data from three 52-week open-label studies.

Authors:  Robin Emsley; Joris Berwaerts; Mariëlle Eerdekens; Michelle Kramer; Rosanne Lane; Pilar Lim; David Hough; Joseph Palumbo
Journal:  Int Clin Psychopharmacol       Date:  2008-11       Impact factor: 1.659

7.  A 3-week, randomized, placebo-controlled trial of asenapine in the treatment of acute mania in bipolar mania and mixed states.

Authors:  Roger S McIntyre; Miriam Cohen; Jun Zhao; Larry Alphs; Thomas A Macek; John Panagides
Journal:  Bipolar Disord       Date:  2009-11       Impact factor: 6.744

8.  Efficacy of iloperidone in the treatment of schizophrenia: initial phase 3 studies.

Authors:  Steven G Potkin; Robert E Litman; Rosarelis Torres; Curt D Wolfgang
Journal:  J Clin Psychopharmacol       Date:  2008-04       Impact factor: 3.153

9.  Functional characterization of the novel antipsychotic iloperidone at human D2, D3, alpha 2C, 5-HT6, and 5-HT1A receptors.

Authors:  Hans O Kalkman; Dominik Feuerbach; Erika Lötscher; Philippe Schoeffter
Journal:  Life Sci       Date:  2003-07-18       Impact factor: 5.037

10.  Efficacy and safety of paliperidone extended-release tablets: results of a 6-week, randomized, placebo-controlled study.

Authors:  Stephen R Marder; Michelle Kramer; Lisa Ford; Els Eerdekens; Pilar Lim; Mariëlle Eerdekens; Adam Lowy
Journal:  Biol Psychiatry       Date:  2007-06-28       Impact factor: 13.382
View more
  3 in total

Review 1.  The role of atypical antipsychotics for treatment of Tourette's syndrome: an overview.

Authors:  Cathy L Budman
Journal:  Drugs       Date:  2014-07       Impact factor: 9.546

2.  Simultaneous Comparison of Efficacy and Tolerability of Second-Generation Antipsychotics in Schizophrenia: Mixed-Treatment Comparison Analysis Based on Head-to-Head Trial Data.

Authors:  Gyu Han Oh; Je-Chun Yu; Kyeong-Sook Choi; Eun-Jeong Joo; Seong-Hoon Jeong
Journal:  Psychiatry Investig       Date:  2014-10-01       Impact factor: 2.505

3.  New Use for Old Drugs: The Protective Effect of Risperidone on Colorectal Cancer.

Authors:  Vincent Chin-Hung Chen; Yi-Hsuan Hsieh; Tzu-Chin Lin; Mong-Liang Lu; Yin-To Liao; Yao-Hsu Yang; Tsai-Ching Hsu; Robert Stewart; Jun-Cheng Weng; Min-Jing Lee; Wei-Che Chiu; Bor-Show Tzang
Journal:  Cancers (Basel)       Date:  2020-06-12       Impact factor: 6.639
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.